Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
Jamjoom PharmaVice President KSA
Jan. 2025Saudi Arabia
Jamjoom PharmaVice President KSA (Former)
Jan. 2025 - Dec. 2025Saudi ArabiaLaunched a full-scale transformation across commercial, governance, and operational functions, redefining company objectives, KPIs, and leadership accountability frameworks. Elevated Jamjoom Pharma to #1 position in Saudi private market sales, becoming the fastest-growing pharmaceutical company across ophthalmology, dermatology, and general medicine portfolios. Delivered high double-digit growth and achieved 38% net profit, driven by optimized portfolio mix, channel diversification, and data-led market intelligence. Achieved a breakthrough transformation in the Government sector, significantly exceeding revenue and access expectations through redesigned go-to-market execution. Led comprehensive commercial restructuring to improve agility, therapeutic focus, and profitability, achieving SAR 650M+ net sales leadership benchmark. Established a strong people-first culture through leadership initiatives such as Open Hour with the VP and multi-layer talent development programs, strengthening succession and engagement.
Hikma PharmaceuticalsManaging Director - GCC
Apr. 2024 - Jan. 2025United Arab EmiratesInitiated a GCC-wide transformation agenda across all functions, aligning strategy, governance, and execution models. Designed and implemented unified GCC KPIs, ensuring consistency in performance management, commercial excellence, and accountability across markets.
Hikma PharmaceuticalsSr. Commercial Director
Jan. 2022 - Apr. 2024Saudi Arabia
Hikma PharmaceuticalsCountry Manager
Apr. 2021 - Jan. 2022Saudi Arabia
Hikma PharmaceuticalsSr. Commercial Director - KSA
Apr. 2021 - Apr. 2024Saudi ArabiaLed Hikma Saudi Arabia to #1 market ranking for the first time in company history. Delivered USD 150M in net sales while achieving 35% EBITDA, supported by disciplined cost optimization and gross-to-net control. Successfully executed multiple new product launches, ensuring rapid uptake and sustainable profitability. Strengthened forecast accuracy and sales–supply integration through enhanced planning platforms and strategic inventory buffers. Built and embedded a new way of working, including comprehensive KPI frameworks across sales, marketing, and distribution. Established a dedicated CHC strategic team for key chains (Nahdi & Al-Dawaa), significantly improving key account penetration. Built a robust Saudization roadmap, developing Saudi leadership pipelines for first-line and mid-management roles. Established the Market Access arm for the Government sector and endorsed the formation of the Medical Department nucleus in KSA.
Hikma PharmaceuticalsMarket Access Manager Biotechnology- MENA
Mar. 2020 - Apr. 2021
Hikma PharmaceuticalsMarket Access Manager- Biotechnology- MENA
Mar. 2020 - Apr. 2021JordanDesigned and implemented MENA-wide Market Access Excellence (MAX) strategy across priority markets. Built strategic partnerships and advocacy platforms with key government stakeholders and HTA bodies. Developed pricing and reimbursement strategies to maximize biotech value access while maintaining sustainability.
Hikma PharmaceuticalsRegional Sales Manager Biosimilars- GCC
Nov. 2016 - Mar. 2020Jordan
Hikma PharmaceuticalsRegional Sales Manager - Biosimilars -Jordan & GCC
Nov. 2016 - Mar. 2020JordanPlayed a pioneering role in shaping the biosimilars market in MENA, introducing the region’s first monoclonal antibody (Remsima®). Established and scaled sales organizations across KSA, GCC countries, and Jordan. Achieved ~100% market share in Jordan for Remsima® within two years. Led fast-track registrations for biosimilar portfolios across KSA, GCC, and Jordan, including UAE registration in under six months. Secured major government tenders, including Saudi Government Hospitals and Kuwait SGH tender. Grew Hikma Biotech revenues from USD 0.6M to over USD 12M within three years, accounting for ~50% of total MENA biotech revenues.
GSKHead of Respiratory Business
Dec. 2014 - Nov. 2016Saudi ArabiaDirected dual-therapy portfolios (Respiratory & CNS), delivering growth through portfolio prioritization, segmentation, and execution excellence. Played a leading role in GSK Transformation Journey, securing 1st Place – Leading Change (2014). Core change leader for new compensation model and job architecture across MENA/CIS, aligning incentives with performance and new ways of working.
GSKHead of Respiratory & CNS Business C&E
Jan. 2013 - Dec. 2014saudi arabia
GSKBusiness Unit Head Respiratory & CNS
Jan. 2013 - Dec. 2014Saudi ArabiaDirected dual therapeutic portfolios (Respiratory & CNS), driving growth through strategic positioning and field force optimization. Awarded 1st Place for Leading Change during GSK’s transformation journey (2014). Core team member in the New Compensation Model & New Job Description transformation, rolled out across MENA/CIS. Led change management initiatives that improved performance transparency and accountability.
GSKNational Sales Manager Public Sector
Feb. 2008 - Jan. 2013Saudi ArabiaLed national public-sector sales strategy covering MOH, military, tenders, and government institutions. Played a key role in securing long-term institutional agreements, including KFSH Agreement (Star Award – 2008). Drove leadership positioning for Augmentin as a standalone brand within MODA, achieving sustained market dominance (2008–2012). Recognized as Best Achiever Sector across the Kingdom (2009–2011).
GSKArea Sales Manager-Institution & Gov. Sector
Nov. 2004 - Jan. 2008Saudi ArabiaManaged and coached high-performing teams across institutional and government sectors. Achieved Best Achiever – Kingdom for three consecutive years, delivering consistent overachievement versus targets. Secured landmark agreements and access wins, strengthening long-term institutional partnerships.
GSKMedical Sales Representative - Institution & Gov. Sector
Feb. 2000 - Nov. 2004Saudi ArabiaAchieved Best Achiever Kingdom recognition for four consecutive years. Contributed significantly to Seretide’s blockbuster launch in the Saudi market (2002). Received GM Award for Best Seretide Access in Public Sector (2002). Played a major role in building Avandia’s leadership position in Saudi Arabia (2004–2010).
The Jordanian Pharmaceutical Manufacturing Co. PLCMedical Representative
Mar. 1998 - Nov. 1999JordanBuilt strong foundations in institutional sales and stakeholder engagement within the Jordanian pharmaceutical market. Developed early expertise in government and hospital-based pharmaceutical access.
Intch is a Professional Networking App for the Future of WorkSee more people like Haitham on Intch
300k+ people
130+ countries
AI matching
Get Intch if you'd like to
1130484 people
15
Behavioral Economist @ Doughit
16
Senior Software Architect / Principal Senior Software Engineer @ QBS Software
23
Finance Director @ Webuild
134032 people
16
Operation director ((COO))
15
Digital Marketing Specialist
16
Senior HR Consultant